company profile of HitGen Inc.，Contact Information for HitGen Inc.

Company Profile

HitGen Inc. (SSE: 688222.SH), is a drug discovery research company with headquarters in Chengdu, China, and subsidiaries in Cambridge, UK and Houston, USA. HitGen has established leading technology platforms to enable the discovery and optimization of small molecules and nucleic acid drugs. Our key technology platforms include world-leading DNA-encoded library technology (DEL), fragment-based drug discovery and structure-based drug design technologies (FBDD/SBDD), as well as the emerging technology platforms for oligonucleotide-based therapeutics (OBT), and targeted protein degradation technology (TPD). Through our diverse and flexible business models, we have built up collaboration partnership with several hundred biopharmaceutical research organizations worldwide. HitGen has multiple programmes from early discovery to clinical trial stage.

more >

Our Company Our Business

Year of Establishment: 2012

Total Assets(USD):

Total Number of Staff: 100-500

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send Inquiry View More

HitGen Inc.
Contact Person : Yang Yu
Tel : Click to View
Fax : --

Send your message to this supplier

From:
To:
HitGen Inc.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification: